Seike Masahiro, Takata Tomoya, Ikeda Mitsunori, Kodama Hajime, Terui Tadashi, Ohtsu Hiroshi
Department of Dermatology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Arch Dermatol Res. 2005 Aug;297(2):68-74. doi: 10.1007/s00403-005-0569-5. Epub 2005 Oct 8.
Histamine is released from mast cells in the skin, causing urticaria and itching. However, little is known about the roles of histamine in development of eczematous lesions in contact dermatitis. Effects of histamine on development of eczematous lesions in contact dermatitis were assessed using histamine-deficient mice in which contact dermatitis was developed by repeated application of diphenylcyclopropenone. Development of eczematous lesions in contact dermatitis was suppressed in histamine-deficient mice compared to wild-type mice. H(1) agonist ((6-12-(4-imidazol)ethylamino)-N-(4-trifluoro- methylphenyl)hepatanecarboxamide) promoted development of eczematous lesions in histamine-deficient mice. H(1) receptor antagonist (loratadine) suppressed development of eczematous lesions in wild-type mice, whereas H(2) agonist (dimaprit) and receptor antagonist (cimetidine) were ineffective. These results suggest that histamine facilitates the development of eczematous lesions in a murine model of contact dermatitis via H(1) receptors.
组胺从皮肤中的肥大细胞释放,导致荨麻疹和瘙痒。然而,关于组胺在接触性皮炎湿疹样病变发展中的作用知之甚少。使用组胺缺陷小鼠评估组胺对接触性皮炎湿疹样病变发展的影响,在组胺缺陷小鼠中通过反复涂抹二苯基环丙烯酮诱发接触性皮炎。与野生型小鼠相比,组胺缺陷小鼠接触性皮炎中湿疹样病变的发展受到抑制。H(1)激动剂((6-12-(4-咪唑基)乙氨基)-N-(4-三氟甲基苯基)庚烷甲酰胺)促进组胺缺陷小鼠中湿疹样病变的发展。H(